@naultjc.bsky.social
1) We recently identified as serum tumor biomarker of fibrolamellar carcinoma, procalcitonin, with @zucmanrossi.bsky.social and @markyarchoan.bsky.social that you can find in www.medrxiv.org/content/10.1...
Serum Procalcitonin: A Novel Tumor Biomarker for Diagnosis and Follow-Up in Fibrolamellar Hepatocellular Carcinoma
Introduction: Fibrolamellar carcinoma (FLC) is a rare primary liver cancer that predominantly affects young patients with normal known serum tumor biomarkers (alpha-fetoprotein (AFP) and CA19-9). An o...
www.medrxiv.org
November 23, 2025 at 10:59 AM
1) We recently identified as serum tumor biomarker of fibrolamellar carcinoma, procalcitonin, with @zucmanrossi.bsky.social and @markyarchoan.bsky.social that you can find in www.medrxiv.org/content/10.1...
Claudia Campani from Cordeliers Research Center received Best clinical poster award in @ILCAnews meeting in Hong Kong
November 20, 2025 at 4:13 AM
Claudia Campani from Cordeliers Research Center received Best clinical poster award in @ILCAnews meeting in Hong Kong
Claudia Campani presenting our work on Molecular based therapy in primary liver cancer refractory to systemic treatments in ILCA meeting in Hong Kong
November 20, 2025 at 3:56 AM
Claudia Campani presenting our work on Molecular based therapy in primary liver cancer refractory to systemic treatments in ILCA meeting in Hong Kong
Our work about « Molecular based targeted therapies in primary liver cancers » presented by Claudia Campani at ESMO precision medicine @myesmo.bsky.social
September 16, 2025 at 11:22 AM
Our work about « Molecular based targeted therapies in primary liver cancers » presented by Claudia Campani at ESMO precision medicine @myesmo.bsky.social
Iron Maiden, Paris 2025
July 20, 2025 at 9:30 AM
Iron Maiden, Paris 2025
Kendrick Lamar/SZA Paris 2025
July 17, 2025 at 6:31 PM
Kendrick Lamar/SZA Paris 2025
Neil Young, Paris 2025
July 13, 2025 at 9:08 PM
Neil Young, Paris 2025
Reposted
📢ONLINE @natgenet.nature.com
📰Cytidine diphosphate diacylglycerol synthase 2 is a synthetic lethal target in mesenchymal-like cancers.
By Tim Arnoldus, Daniel S. Peeper and colleagues.
⬇️
www.nature.com/articles/s41...
📰Cytidine diphosphate diacylglycerol synthase 2 is a synthetic lethal target in mesenchymal-like cancers.
By Tim Arnoldus, Daniel S. Peeper and colleagues.
⬇️
www.nature.com/articles/s41...
Cytidine diphosphate diacylglycerol synthase 2 is a synthetic lethal target in mesenchymal-like cancers - Nature Genetics
The paralogs cytidine diphosphate diacylglycerol synthase 1 and 2 form a potentially targetable synthetic lethal relationship in mesenchymal-like cancers that involves disruption of lipid metabolism.
www.nature.com
July 8, 2025 at 4:18 PM
📢ONLINE @natgenet.nature.com
📰Cytidine diphosphate diacylglycerol synthase 2 is a synthetic lethal target in mesenchymal-like cancers.
By Tim Arnoldus, Daniel S. Peeper and colleagues.
⬇️
www.nature.com/articles/s41...
📰Cytidine diphosphate diacylglycerol synthase 2 is a synthetic lethal target in mesenchymal-like cancers.
By Tim Arnoldus, Daniel S. Peeper and colleagues.
⬇️
www.nature.com/articles/s41...
Joe Satriani and Steve Vaï, Paris 2025
June 23, 2025 at 4:44 AM
Joe Satriani and Steve Vaï, Paris 2025
Pr Éric Trepo on genetic prédisposition to HCC on alcohol related liver Disease in the Paris Liver Cancer Group Day, June 2025
June 19, 2025 at 9:22 PM
Pr Éric Trepo on genetic prédisposition to HCC on alcohol related liver Disease in the Paris Liver Cancer Group Day, June 2025
Paris Liver Cancer Group day, 19 June 2025.
June 19, 2025 at 9:21 PM
Paris Liver Cancer Group day, 19 June 2025.
Paris Liver Cancer Group day, 19 June 2025.
June 19, 2025 at 9:19 PM
Paris Liver Cancer Group day, 19 June 2025.
🧵1/
Can systematic biopsies during RFA improve how we diagnose & manage hepatocellular carcinoma (HCC)?
Our study was recently published in J hep reports. Here's what we found 👇
www.jhep-reports.eu/article/S258...
Can systematic biopsies during RFA improve how we diagnose & manage hepatocellular carcinoma (HCC)?
Our study was recently published in J hep reports. Here's what we found 👇
www.jhep-reports.eu/article/S258...
Utility of tumor and non-tumor biopsies during percutaneous radiofrequency ablation for hepatocellular carcinoma
We aim to assess the safety and diagnostic/prognostic value of tumor and non-tumor
biopsies systematically collected during radiofrequency ablation (RFA) of hepatocellular
carcinoma (HCC).
www.jhep-reports.eu
April 25, 2025 at 6:24 PM
🧵1/
Can systematic biopsies during RFA improve how we diagnose & manage hepatocellular carcinoma (HCC)?
Our study was recently published in J hep reports. Here's what we found 👇
www.jhep-reports.eu/article/S258...
Can systematic biopsies during RFA improve how we diagnose & manage hepatocellular carcinoma (HCC)?
Our study was recently published in J hep reports. Here's what we found 👇
www.jhep-reports.eu/article/S258...
Reposted
Routine [18F]FCH and [18F]FDG PET-CT for tumour staging in all patients with a 1st diagnosis of hepatocellular carcinoma has limited clinical value
Guidelines should continue to emphasise morphological imaging (eg MRI & CT) for staging
#OncSky #MedSky @oncoalert.bsky.social @naultjc.bsky.social
Guidelines should continue to emphasise morphological imaging (eg MRI & CT) for staging
#OncSky #MedSky @oncoalert.bsky.social @naultjc.bsky.social
New research - Nault et al - [¹⁸F]fluorodeoxyglucose and [¹⁸F]fluorocholine PET-CT for staging optimisation and treatment modification in hepatocellular carcinoma (PET-HCC01): a prospective multicentre study
https://buff.ly/419ebHP
#MedSky #OncSky #LiverSky @naultjc.bsky.social
https://buff.ly/419ebHP
#MedSky #OncSky #LiverSky @naultjc.bsky.social
February 21, 2025 at 7:03 AM
Routine [18F]FCH and [18F]FDG PET-CT for tumour staging in all patients with a 1st diagnosis of hepatocellular carcinoma has limited clinical value
Guidelines should continue to emphasise morphological imaging (eg MRI & CT) for staging
#OncSky #MedSky @oncoalert.bsky.social @naultjc.bsky.social
Guidelines should continue to emphasise morphological imaging (eg MRI & CT) for staging
#OncSky #MedSky @oncoalert.bsky.social @naultjc.bsky.social
Reposted
New research - Nault et al - [¹⁸F]fluorodeoxyglucose and [¹⁸F]fluorocholine PET-CT for staging optimisation and treatment modification in hepatocellular carcinoma (PET-HCC01): a prospective multicentre study
https://buff.ly/419ebHP
#MedSky #OncSky #LiverSky @naultjc.bsky.social
https://buff.ly/419ebHP
#MedSky #OncSky #LiverSky @naultjc.bsky.social
February 21, 2025 at 6:00 AM
New research - Nault et al - [¹⁸F]fluorodeoxyglucose and [¹⁸F]fluorocholine PET-CT for staging optimisation and treatment modification in hepatocellular carcinoma (PET-HCC01): a prospective multicentre study
https://buff.ly/419ebHP
#MedSky #OncSky #LiverSky @naultjc.bsky.social
https://buff.ly/419ebHP
#MedSky #OncSky #LiverSky @naultjc.bsky.social
Fire walk with him
January 16, 2025 at 8:03 PM
Fire walk with him
Reposted
New research - Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial
www.thelancet.com/journals/lan...
#GastroSky #OncSky #MedSky @oncoalert.bsky.social
www.thelancet.com/journals/lan...
#GastroSky #OncSky #MedSky @oncoalert.bsky.social
January 15, 2025 at 6:07 AM
New research - Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial
www.thelancet.com/journals/lan...
#GastroSky #OncSky #MedSky @oncoalert.bsky.social
www.thelancet.com/journals/lan...
#GastroSky #OncSky #MedSky @oncoalert.bsky.social
December 2, 2024 at 2:57 PM
November 23, 2024 at 4:16 PM